Beyond SQUARE FEET

Corporate Real Estate Solutions | Workplace Strategy | Tenant Representation

First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals

Here are San Diego’s top 10 first-quarter deals, based on PitchBook data from the Venture Monitor report.

Vividion Therapeutics $50 million BioPharma
F1 Oncology $44 million Anti-cancer
Biological Dynamics $28.9 million Anti-cancer
Dauntless Pharmaceuticals $25 million BioPharma
Jecure Therapeutics $20 million BioPharma
Neurelis $20 million BioPharma
Oncternal Therapeutics $18.4 million Anti-cancer
Genoa Pharmaceuticals $16.6 million BioPharma
Avidity Biosciences $16 million BioPharma
Echo Laboratories $12.9 million Healthtech

via First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals | Xconomy

Comments are closed.